Savara (Denmark) reported higher prevalence of Autoimmune Pulmonary Alveolar Proteinosis based on updated claims data analysis.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Savara (Denmark) reported higher prevalence of Autoimmune Pulmonary Alveolar Proteinosis based on updated claims data analysis.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Savara (Denmark)
company in Hørsholm, Denmark
Nothing else this week.
Coverage
Newest first; wire copies grouped- Business WireSavara Announces New U.S. Health Claims Data Analysis Finds Over 50% Increase in the Estimated Number of Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) Patients Compared to Previous Claims